MR-directed ultrasound of MRI-detected lesions was useful for decision making as part of the diagnostic workup. Malignant lesions were likely to have an ultrasound correlate, especially when they presented as masses on MRI. However, the sonographic findings of these lesions were often subtle, and careful scanning technique was needed for successful MRI-ultrasound correlation.
Axillary lymph nodes with abnormal US findings can be sampled with high accuracy and without major complications by using a modified 14-gauge CNB technique.
Rationale and objectives
To evaluate the feasibility and advantages of a combined high temporal/high spatial resolution protocol for DCE-MRI of the breast.
Materials and methods
Twenty-three patients with enhancing lesions were imaged at 3T. The acquisition protocol consisted of a series of bilateral, fat-suppressed ‘ultrafast’ acquisitions, with 6.9-9.9 s temporal resolution, for the first minute following contrast injection; followed by four high spatial resolution acquisitions with 60–79.5 s temporal resolution. All images were acquired with standard uniform Fourier sampling. A filtering method was developed to reduce noise and detect significant enhancement in the high temporal resolution images. Time-of-arrival (TOA) was defined as the time at which each voxel first satisfied all the filter conditions, relative to the time of initial arterial enhancement.
Results
Ultrafast images improved visualization of the vasculature feeding and draining lesions. A small percentage of the entire field-of-view (<6%) enhanced significantly in the 30 s following contrast injection. Lesion conspicuity was highest in early ultrafast images, especially in cases with marked parenchymal enhancement. While the sample size was relatively small, the average TOA for malignant lesions was significantly shorter than the TOA for benign lesions. Significant differences were also measured in other parameters descriptive of early contrast media uptake kinetics (p<0.05).
Conclusions
Ultrafast imaging in the first minute of breast DCE-MRI has the potential to add valuable information regarding early contrast dynamics. Ultrafast imaging could allow radiologists to confidently identify lesions in the presence of marked background parenchymal enhancement.
Mass lesion segmentation on mammograms is a challenging task since mass lesions are usually embedded and hidden in varying densities of parenchymal tissue structures. In this article, we present a method for automatic delineation of lesion boundaries on digital mammograms. This method utilizes a geometric active contour model that minimizes an energy function based on the homogeneities inside and outside of the evolving contour. Prior to the application of the active contour model, a radial gradient index (RGI)-based segmentation method is applied to yield an initial contour closer to the lesion boundary location in a computationally efficient manner. Based on the initial segmentation, an automatic background estimation method is applied to identify the effective circumstance of the lesion, and a dynamic stopping criterion is implemented to terminate the contour evolution when it reaches the lesion boundary. By using a full-field digital mammography database with 739 images, we quantitatively compare the proposed algorithm with a conventional region-growing method and an RGI-based algorithm by use of the area overlap ratio between computer segmentation and manual segmentation by an expert radiologist. At an overlap threshold of 0.4, 85% of the images are correctly segmented with the proposed method, while only 69% and 73% of the images are correctly delineated by our previous developed region-growing and RGI methods, respectively. This resulting improvement in segmentation is statistically significant.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.